Lisa A Jackson

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. doi request reprint Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Lisa A Jackson
    The Group Health Research Institute, Group Health, Seattle, WA, USA
    Vaccine 31:3585-93. 2013
  2. doi request reprint Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, United States
    Vaccine 31:3577-84. 2013
  3. doi request reprint Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
    Lisa A Jackson
    The Group Health Research Institute, Group Health, Seattle, Washington, United States
    Vaccine 31:3594-602. 2013
  4. doi request reprint Vaccination site and risk of local reactions in children 1 through 6 years of age
    Lisa A Jackson
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Pediatrics 131:283-9. 2013
  5. pmc Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons
    Lisa A Jackson
    Group Health Research Institute, Seattle, WA 98101, USA
    J Infect Dis 206:811-20. 2012
  6. doi request reprint Hospitalizations to treat herpes zoster in older adults: causes and validated rates
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington 98101, USA
    Clin Infect Dis 47:754-9. 2008
  7. doi request reprint Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination
    Lisa A Jackson
    Group Health Center for Health Studies, University of Washington, Seattle, Washington, USA
    Pediatrics 121:e646-52. 2008
  8. doi request reprint Pneumococcal vaccination of elderly adults: new paradigms for protection
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington 98101, USA
    Clin Infect Dis 47:1328-38. 2008
  9. ncbi request reprint Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Lisa A Jackson
    Group Health Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 25:4029-37. 2007
  10. ncbi request reprint Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington, USA
    Pediatrics 118:2032-7. 2006

Detail Information

Publications69

  1. doi request reprint Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Lisa A Jackson
    The Group Health Research Institute, Group Health, Seattle, WA, USA
    Vaccine 31:3585-93. 2013
    ..This reflects a significant unmet medical need for alternative strategies to protect older adults against pneumococcal infection, which may be met by the 13-valent polysaccharide conjugate vaccine (PCV13)...
  2. doi request reprint Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, United States
    Vaccine 31:3577-84. 2013
    ..Pneumococcal conjugate vaccines are efficacious against pneumococcal disease in children and may also offer advantages in adults...
  3. doi request reprint Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
    Lisa A Jackson
    The Group Health Research Institute, Group Health, Seattle, Washington, United States
    Vaccine 31:3594-602. 2013
    ..Unlike free polysaccharide vaccines, pneumococcal polysaccharide conjugate vaccines (PCVs) induce a T cell-dependent immune response and have the potential to provide an extended duration of protection with repeated vaccinations...
  4. doi request reprint Vaccination site and risk of local reactions in children 1 through 6 years of age
    Lisa A Jackson
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Pediatrics 131:283-9. 2013
    ..Our objective was to assess whether the occurrence of medically attended local reactions to intramuscularly administered vaccines varies by injection site (arm versus thigh) in children 1 to 6 years of age...
  5. pmc Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons
    Lisa A Jackson
    Group Health Research Institute, Seattle, WA 98101, USA
    J Infect Dis 206:811-20. 2012
    ..Conclusions: AS03 adjuvant system improves the immune response to inactivated 2009 H1N1 influenza vaccine in both younger and older adults and is generally well tolerated. ClinicalTrials.gov NCT00963157...
  6. doi request reprint Hospitalizations to treat herpes zoster in older adults: causes and validated rates
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington 98101, USA
    Clin Infect Dis 47:754-9. 2008
    ..However, a zoster diagnosis code may not be a specific indicator of severe zoster illness, because the code may be assigned to a hospitalization for another cause in a person with coincident zoster...
  7. doi request reprint Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination
    Lisa A Jackson
    Group Health Center for Health Studies, University of Washington, Seattle, Washington, USA
    Pediatrics 121:e646-52. 2008
    ....
  8. doi request reprint Pneumococcal vaccination of elderly adults: new paradigms for protection
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington 98101, USA
    Clin Infect Dis 47:1328-38. 2008
    ....
  9. ncbi request reprint Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Lisa A Jackson
    Group Health Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 25:4029-37. 2007
    ..A booster response to the challenge vaccination was not observed. Administration of a 1 ml dose of PnC vaccine is more immunogenic than 0.5 ml of PnPS vaccine in elderly adults previously vaccinated with PnPS vaccine...
  10. ncbi request reprint Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington, USA
    Pediatrics 118:2032-7. 2006
    ..We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations...
  11. doi request reprint A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, WA, USA
    Pediatr Infect Dis J 28:86-91. 2009
    ....
  12. pmc Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, Group Health Cooperative, Seattle, USA
    BMC Infect Dis 9:37. 2009
    ..To assess contemporary patterns of pneumococcal vaccination and revaccination of adults, we conducted a cross-sectional study of adults enrolled in medical care organizations (MCOs) participating in the Vaccine Safety Datalink project...
  13. doi request reprint Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents
    Lisa A Jackson
    Group Health Center for Health Studies, Seattle, Washington 98101, USA
    Clin Infect Dis 49:e1-10. 2009
    ..This study compares the safety and immunogenicity of the Novartis Vaccines investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, with the licensed meningococcal conjugate vaccine, Menactra...
  14. doi request reprint Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, United States
    Vaccine 27:4912-6. 2009
    ..In general the risk of medically attended local reactions was low and did not differ with concomitant or sequential administration of diphtheria toxoid containing vaccines...
  15. pmc Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study
    Lisa A Jackson
    Group Health Research Institute, Seattle WA, USA
    BMC Infect Dis 9:165. 2009
    ..Local reactions are the most commonly reported adverse events following tetanus and diphtheria toxoid (Td) vaccine and the risk of local reactions may increase with number of prior Td vaccinations...
  16. doi request reprint Injection site and risk of medically attended local reactions to acellular pertussis vaccine
    Lisa A Jackson
    Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Pediatrics 127:e581-7. 2011
    ..To assess whether the risk of medically attended local reactions to the fifth dose of the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine varies according to injection site (arm versus thigh)...
  17. pmc A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, United States of America
    PLoS ONE 6:e20102. 2011
    ....
  18. pmc Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women
    Lisa A Jackson
    The Group Health Research Institute, Group Health, Seattle, Washington, USA
    J Infect Dis 204:854-63. 2011
    ..Although pregnant women are at increased risk of severe illness following influenza infection, there is relatively little information on the immunogenicity of influenza vaccines administered during pregnancy...
  19. ncbi request reprint Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Pediatrics 117:620-5. 2006
    ..It is not known whether these reactions can be prevented with prophylactic use of acetaminophen or ibuprofen...
  20. ncbi request reprint Evidence of bias in estimates of influenza vaccine effectiveness in seniors
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Int J Epidemiol 35:337-44. 2006
    ..Since a protective effect of vaccination should be specific to influenza season, evaluation of non-influenza periods could indicate the possible contribution of bias to the estimates observed during influenza season...
  21. ncbi request reprint Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population
    Lisa A Jackson
    Center for Health Studies, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 24:151-6. 2006
    ..5 for both comparisons with the third PPV group). These findings do not suggest that a third PPV dose is associated with an increased risk of medically attended injection site reactions compared with a first or second PPV dose...
  22. ncbi request reprint Burden of community-onset Escherichia coli bacteremia in seniors
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, and Department of Epidemiology, University of Washington, Seattle, Washington 98101, USA
    J Infect Dis 191:1523-9. 2005
    ..Although Escherichia coli is a well-recognized cause of urinary tract infection in seniors, little is known about the burden of invasive E. coli infection in this population...
  23. ncbi request reprint Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    Vaccine 23:3697-703. 2005
    ..Fever was uncommon and did not vary by study group. The rate of local reactions increased with higher volumes of PCV and the rate following 2.0 ml of PCV was comparable to that following 0.5 ml PPV...
  24. pmc Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Group Health Research Institute, Seattle, Washington, USA
    BMC Infect Dis 10:71. 2010
    ..The aim of this study was to assess the efficacy, safety, reactogenicity, and immunogenicity of a trivalent inactivated split virion influenza vaccine (TIV) in healthy adults over two influenza seasons in the US...
  25. ncbi request reprint Effectiveness of pneumococcal polysaccharide vaccine in older adults
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    N Engl J Med 348:1747-55. 2003
    ..In a large population of older adults, we assessed the effectiveness of the pneumococcal vaccine...
  26. pmc Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study
    Sascha Dublin
    Group Health Research Institute, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 21:1173-82. 2012
    ..To test whether angiotensin-converting enzyme (ACE) inhibitor use is associated with decreased risk of community-acquired pneumonia in older adults...
  27. doi request reprint Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study
    Jennifer C Nelson
    Biostatistics Unit, Group Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101, USA
    Am J Epidemiol 177:131-41. 2013
    ..Although lack of a controlled experiment presents numerous challenges, implementation of group sequential monitoring methods in observational safety surveillance studies is promising and warrants further investigation...
  28. ncbi request reprint Chlamydia pneumoniae infection and risk of lung cancer
    Alyson J Littman
    Department of Epidemiology, University of Washington, 1100 Fairview Avenue North, PO Box 19024, Seattle 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 13:1624-30. 2004
    ..Future studies using precise measures of chronic C. pneumoniae status are needed to better determine the role of this organism in the etiology of lung cancer...
  29. doi request reprint Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study
    Jennifer C Nelson
    Group Health Research Institute, Seattle, WA, USA
    Am J Public Health 99:S389-97. 2009
    ..We studied compliance with multiple-dose vaccine schedules, assessed factors associated with noncompliance, and examined timeliness of series completion among older children, adolescents, and adults...
  30. doi request reprint Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults
    Jennifer C Nelson
    Group Health Center for Health Studies, Seattle, WA, United States
    Vaccine 26:4947-54. 2008
    ....
  31. doi request reprint Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study
    Michael L Jackson
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Lancet 372:398-405. 2008
    ..We therefore assessed whether influenza vaccination is associated with a reduced risk of community-acquired pneumonia in immunocompetent elderly people after controlling for health status indicators...
  32. ncbi request reprint Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Int J Epidemiol 35:345-52. 2006
    ....
  33. ncbi request reprint Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children
    Kathleen M Neuzil
    Program for Appropriate Technology in Health, School of Medicine, University of Washington, Seattle, Seattle, WA 98107, USA
    J Infect Dis 194:1032-9. 2006
    ..This study assessed the need for a second dose of TIV in this age group...
  34. ncbi request reprint The burden of community-acquired pneumonia in seniors: results of a population-based study
    Michael L Jackson
    Center for Health Studies, Group Health Cooperative, University of Washington, Seattle, USA
    Clin Infect Dis 39:1642-50. 2004
    ....
  35. pmc Statin use and risk of community acquired pneumonia in older people: population based case-control study
    Sascha Dublin
    Group Health Center for Health Studies, 1730 Minor Avenue, Suite 1600, Seattle WA 98101 1448, USA
    BMJ 338:b2137. 2009
    ..To test the hypothesis that hydroxymethyl glutaryl coenzyme A reductase inhibitors (statins) may decrease the risk of community acquired pneumonia...
  36. pmc Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study
    Sascha Dublin
    Group Health Research Institute, Seattle, Washington 98101, USA
    J Am Geriatr Soc 59:1899-907. 2011
    ..To examine whether use of opioids or benzodiazepines is associated with risk of community-acquired pneumonia in older adults...
  37. pmc Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study
    Sascha Dublin
    Group Health Research Institute, Seattle, Washington 98101 1448, USA
    Pharmacoepidemiol Drug Saf 19:792-802. 2010
    ..To examine whether use of proton pump inhibitors (PPIs) and H2 blockers is associated with increased pneumonia risk...
  38. doi request reprint Risk factors for community-acquired pneumonia in immunocompetent seniors
    Michael L Jackson
    Group Health Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA, USA
    J Am Geriatr Soc 57:882-8. 2009
    ..To identify risk factors for developing community-acquired pneumonia (CAP) in seniors...
  39. ncbi request reprint Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study
    Onchee Yu
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 16:736-45. 2007
    ..To test the hypothesis that hepatitis B vaccine increases the risk of ATD, we conducted a case-control study, within the Vaccine Safety Datalink project...
  40. ncbi request reprint Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study
    Michael L Jackson
    Group Health Center for Health Studies, Seattle, WA 98101 1448, USA
    Pharmacoepidemiol Drug Saf 16:790-6. 2007
    ..We sought to determine whether vaccinations are associated with changes in International Normalized Ratio (INR) in persons on long-term warfarin therapy...
  41. doi request reprint Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness
    Jennifer Clark Nelson
    Group Health Research Institute, Seattle, WA 98101, USA
    J Clin Epidemiol 66:S110-21. 2013
    ..Study methods that collect and incorporate more comprehensive confounder data on a validation cohort may reduce confounding bias...
  42. doi request reprint Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data
    Jennifer C Nelson
    Biostatistics Unit, Group Health Research Institute, Seattle, WA 98101, USA
    Pharmacoepidemiol Drug Saf 21:62-71. 2012
    ....
  43. ncbi request reprint Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia
    Ru Chien Chi
    Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, USA
    J Am Geriatr Soc 54:115-20. 2006
    ..To describe baseline characteristics and clinical outcomes of older adults with pneumococcal bacteremia, compare the frequency of serious outcomes according to pneumococcal vaccination status, and assess factors associated with mortality...
  44. ncbi request reprint Chlamydia pneumoniae and lung cancer: epidemiologic evidence
    Alyson J Littman
    Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 14:773-8. 2005
    ..g., studies that involve detection of C. pneumoniae in pulmonary specimens obtained before cancer onset) could be explored and may shed additional light on this important association...
  45. ncbi request reprint Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101 1448, USA
    Am J Epidemiol 156:634-40. 2002
    ..06, 95% CI: 0.63, 1.78) or inactivity (May through October) (HR = 1.34, 95% CI: 0.76, 2.36). These results suggest that the benefit of influenza vaccine for older adults does not extend to protection against recurrent coronary events...
  46. doi request reprint New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors
    Jennifer Clark Nelson
    Group Health Center for Health Studies, Seattle, WA 98101, USA
    J Clin Epidemiol 62:687-94. 2009
    ..In this paper, we provide a methodological examination of the potential sources of bias in observational studies of influenza vaccine effectiveness in seniors and propose design and analysis strategies to reduce bias in future studies...
  47. ncbi request reprint Newly detected atrial fibrillation and compliance with antithrombotic guidelines
    Nicole L Glazer
    Cardiovascular Health Research Unit and Department of Epidemiology, University of Washington, 1730 Minor Avenue, Seattle, WA 98101, USA
    Arch Intern Med 167:246-52. 2007
    ..Our objective was to assess compliance with antithrombotic guidelines and to identify patient characteristics associated with warfarin use...
  48. doi request reprint Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors?
    Michael L Jackson
    Group Health Research Institute, Seattle, WA, USA
    Pharmacoepidemiol Drug Saf 20:858-65. 2011
    ..We explored reasons why adjustment for comorbid illness defined from International Classification of Diseases (ICD) codes fails to remove confounding...
  49. ncbi request reprint Azithromycin for the secondary prevention of coronary events
    J Thomas Grayston
    Department of Epidemiology, University of Washington, Seattle 98195, USA
    N Engl J Med 352:1637-45. 2005
    ..We evaluated the efficacy of one year of azithromycin treatment for the secondary prevention of coronary events...
  50. ncbi request reprint Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, University of Washington, Seatle, WA, USA
    Pediatr Infect Dis J 21:781-6. 2002
    ....
  51. ncbi request reprint Prior lung disease and risk of lung cancer in a large prospective study
    Alyson J Littman
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Cancer Causes Control 15:819-27. 2004
    ..Identifying factors that increase a smoker's risk of developing lung cancer may help scientists to better understand the etiology of lung cancer and more effectively target high-risk groups for screening...
  52. ncbi request reprint Postpartum varicella vaccination: is the vaccine virus excreted in breast milk?
    Kari Bohlke
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101 1448, USA
    Obstet Gynecol 102:970-7. 2003
    ..To evaluate whether the varicella vaccine virus is detected in breast milk after vaccination of breast-feeding women and whether there is serologic evidence of exposure of the infant to varicella virus after maternal vaccination...
  53. ncbi request reprint Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccine
    Patti J Benson
    Group Health Center for Health Studies, Seattle, Washington 98101 1448, USA
    Hum Vaccin 4:234-7. 2008
    ....
  54. pmc Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers
    Alyson J Littman
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, M4 B402, Seattle, WA 98109 1024, USA
    Clin Diagn Lab Immunol 11:615-7. 2004
    ..39 for IgA and 0.53 for IgG. Measurement error likely attenuates C. pneumoniae-disease associations; the magnitude of attenuation can be estimated from results of studies such as this one...
  55. doi request reprint Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease
    M Ashworth Dirac
    Seattle Biomedical Research Institute, 307 Westlake Avenue North, Seattle, WA 98109, USA
    Am J Respir Crit Care Med 186:684-91. 2012
    ..Several host traits have been suggested or confirmed as risk factors. Potential environmental and behavioral risk factors have also been proposed. Few have been evaluated in comparative studies...
  56. ncbi request reprint Vaccinations and risk of central nervous system demyelinating diseases in adults
    Frank Destefano
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Arch Neurol 60:504-9. 2003
    ..Several case reports of the onset or exacerbation of multiple sclerosis or other demyelinating conditions shortly after vaccination have suggested that vaccines may increase the risk of demyelinating diseases...
  57. ncbi request reprint Influenza vaccination and risk of incident myocardial infarction
    James D Heffelfinger
    Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Hum Vaccin 2:161-6. 2006
    ..We examined the association between influenza vaccination and risk of incident myocardial infarction (MI) in persons at least 65 years of age in a population-based case-control study...
  58. doi request reprint Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
    Eric K France
    Department of Preventive Medicine, Kaiser Pemanente Colorado, Denver, CO 80231, USA
    Pediatrics 121:e687-92. 2008
    ..The measles-mumps-rubella vaccine has been associated with immune thrombocytopenia purpura in 2 small studies...
  59. ncbi request reprint Effectiveness of influenza vaccination
    Jennifer C Nelson
    N Engl J Med 357:2728-9; author reply 2730-1. 2007
  60. ncbi request reprint Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002
    Aisha O Jumaan
    Centers for Disease Control and Prevention, Atlanta, Georgia 30345, USA
    J Infect Dis 191:2002-7. 2005
    ..We assessed the impact that varicella vaccination has on the incidence of varicella and of HZ...
  61. ncbi request reprint Influenza- and RSV-associated hospitalizations among adults
    John P Mullooly
    Center for Health Research, Kaiser Permanente Northwest, 3800 N Interstate Ave, Portland, OR 97227, United States
    Vaccine 25:846-55. 2007
    ..Excess hospitalization estimates among adults aged > or = 65 years and high-risk 50-64 year olds during the influenza season suggest that these groups should have priority for influenza vaccine during vaccine shortages...
  62. ncbi request reprint Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants
    Eric K France
    Department of Preventive Medicine and Clinical Research Unit, Kaiser Permanente Colorado, Denver, CO 80231, USA
    Arch Pediatr Adolesc Med 160:1277-83. 2006
    ..To determine whether influenza vaccination of pregnant women prevents visits for respiratory illness in their infants born during the influenza season...
  63. ncbi request reprint Mortality benefits of influenza vaccination in elderly people: an ongoing controversy
    Lone Simonsen
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    Lancet Infect Dis 7:658-66. 2007
    ..The remaining evidence base is currently insufficient to indicate the magnitude of the mortality benefit, if any, that elderly people derive from the vaccination programme...
  64. ncbi request reprint Safety of the trivalent inactivated influenza vaccine among children: a population-based study
    Eric K France
    Clinical Research Unit, Kaiser Permanente Colorado, Denver, USA
    Arch Pediatr Adolesc Med 158:1031-6. 2004
    ..To our knowledge, there are no published population-based studies on the safety of the inactivated trivalent influenza vaccine among children...
  65. ncbi request reprint Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women
    Lisa Lindsay
    Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, NC, USA
    Am J Epidemiol 163:838-48. 2006
    ..Findings estimate that 20-43 pregnant/postpartum women would need to be vaccinated with an 80% effective vaccine to prevent one influenza-like illness episode...
  66. doi request reprint Benefits of examining influenza vaccine associations outside of influenza season
    Lisa A Jackson
    Am J Respir Crit Care Med 178:439-40. 2008
  67. ncbi request reprint Childhood vaccinations and risk of asthma
    Frank Destefano
    Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 21:498-504. 2002
    ..A few previous studies have suggested that childhood vaccines, particularly whole cell pertussis vaccine, may increase the risk of asthma. We evaluated the suggested association between childhood vaccinations and risk of asthma...
  68. ncbi request reprint Evaluating diabetes mellitus as a risk factor for community-acquired infections
    Lisa A Jackson
    Clin Infect Dis 41:289-90. 2005
  69. ncbi request reprint To rule out confounding, observational studies of influenza vaccine need to include analyses during the "preinfluenza period"
    Michael L Jackson
    Arch Intern Med 167:1553-4; author reply 1554-5. 2007